Clinical impact of PSMA-based (18)F—DCFBC PET/CT imaging in patients with biochemically recurrent prostate cancer after primary local therapy

PURPOSE: The purpose of our study was to assess (18)F–DCFBC PET/CT, a PSMA targeted PETagent, for lesion detection and clinical management of biochemical relapse in prostate cancer patients after primary treatment. METHODS: This is a prospective IRB-approved study of 68 patients with documented bioc...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Eur J Nucl Med Mol Imaging
Main Authors: Mena, Esther, Lindenberg, Maria L., Shih, Joanna H., Adler, Stephen, Harmon, Stephanie, Bergvall, Ethan, Citrin, Deborah, Dahut, William, Ton, Anita T., McKinney, Yolanda, Weaver, Junaita, Eclarinal, Philip, Forest, Alicia, Afari, George, Bhattacharyya, Sibaprasad, Mease, Ronnie C., Merino, Maria J., Pinto, Peter, Wood, Bradford J., Jacobs, Paula, Pomper, Martin G., Choyke, Peter L., Turkbey, Baris
Formato: Artigo
Idioma:Inglês
Publicado em: 2017
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7983162/
https://ncbi.nlm.nih.gov/pubmed/28894899
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00259-017-3818-x
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados